MSL
AGN.PRA

Mackay Shields LLC’s Allergan plc AGN.PRA Stock Holding History

Mackay Shields LLC’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-40,845
Closed -$23.9M – 1253
2017
Q4 		$23.9M Sell
40,845
-551
-1% -$356K 0.87% 44
2017
Q3 		$30.4M Buy
41,396
+137
+0.3% +$114K 1.13% 36
2017
Q2 		$35.7M Buy
41,259
+328
+0.8% +$275K 1.51% 24
2017
Q1 		$34.7M Buy
40,931
+306
+0.8% +$254K 1.58% 20
2016
Q4 		$30.9M Sell
40,625
-540
-1% -$408K 1.48% 20
2016
Q3 		$33.7M Sell
41,165
-88
-0.2% -$76.1K 1.52% 22
2016
Q2 		$34.4M Buy
41,253
+15,040
+57% +$12.6M 1.71% 16
2016
Q1 		$24.1M Sell
26,213
-207
-0.8% -$198K 1.31% 31
2015
Q4 		$27.2M Sell
26,420
-11
-0% -$11K 1.48% 24
2015
Q3 		$24.9M Sell
26,431
-299
-1% -$312K 1.3% 25
2015
Q2 		$27.9M Buy
+26,730
New +$28M 1.43% 20

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Mackay Shields LLC's AGN.PRA Position: Q1 2018 in Review

Mackay Shields LLC sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 40,845 shares — an estimated $23.9M sold.

Mackay Shields LLC first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $35.7M in Q2 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Mackay Shields LLC reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Mackay Shields LLC sold 40,845 Allergan plc shares in Q1 2018, an estimated $23.9M.
  • Mackay Shields LLC first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Mackay Shields LLC's Allergan plc position peaked at $35.7M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Mackay Shields LLC's 13F filing for Q1 2018, filed 3 May 2018.